Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Anal Cancer Pipeline Review, H2 2017 - Thrapeutics Review of 14 Companies & Drug Profiles - Research and Markets

Research and Markets
Posted on: 28 Aug 17

The "Anal Cancer - Pipeline Review, H2 2017" report has been added to Research and Markets' offering.

Anal Cancer - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Anal Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Anal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Anal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I and Preclinical stages are 10, 3 and 4 respectively.

Anal Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

  1. Introduction
  2. Anal Cancer - Overview
  3. Anal Cancer - Therapeutics Development
  4. Pipeline Overview
  5. Pipeline by Companies
  6. Products under Development by Companies
  7. Anal Cancer - Therapeutics Assessment
  8. Assessment by Target
  9. Assessment by Mechanism of Action
  10. Assessment by Route of Administration
  11. Assessment by Molecule Type
  12. Anal Cancer - Companies Involved in Therapeutics Development
  • Advaxis Inc
  • Amgen Inc
  • Atara Biotherapeutics Inc
  • Bayer AG
  • BeiGene Ltd
  • Eli Lilly and Company
  • Immunovaccine Inc
  • ISA Pharmaceuticals BV
  • Merck & Co Inc
  • Ono Pharmaceutical Co Ltd
  • Oryx GmbH & Co KG
  • PDS Biotechnology Corp
  • Sun Pharma Advanced Research Company Ltd
  • Taiwan Liposome Company Ltd

For more information about this report visit https://www.researchandmarkets.com/research/4vtslk/anal_cancer

View source version on businesswire.com: http://www.businesswire.com/news/home/20170828005550/en/

Business Wire
www.businesswire.com

Last updated on: 28/08/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.